Signal Transduction and Targeted Therapy makes all content freely available to all researchers worldwide, ensuring maximum dissemination of content through the nature.com platform. Content is published online on a weekly basis to provide timely communication to the community and keep publication times to a minimum.
Publishing open access
Signal Transduction and Targeted Therapy is an open access journal: authors pay an article processing charge (APC) for their accepted articles to be open access online and freely accessible, immediately upon publication, under a Creative Commons license.
To facilitate self-archiving Springer Nature deposits open access articles in PubMed Central and Europe PubMed Central on publication. Authors are also permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication.
Visit our open research site for detailed information about publishing open access in Signal Transduction and Targeted Therapy:
- About Creative Commons licensing
- Creative Commons license options and article processing charges(APCs) for Signal Transduction and Targeted Therapy
- APC payment FAQs
- Help in identifying funding for APCs
- Fee waiver policy
- Self-archiving and deposition
- Compliance with funding body requirements